US-veteran mental health trial patient recruitment complete
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The trial evaluates a novel single-lead ECG algorithm designed to screen for major depressive episodes in veterans with suspected sleep apnea. Positive interim results from earlier participants have been reported, and full trial results are expected soon, which will guide future regulatory and commercial engagements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from TrivarX
- Acquisition of Stabl-Im technology and Private Placement
- Reinstatement to Official Quotation
- Extension of Trading Suspension
- Suspension from Quotation
- Inadvertent Lift of Trading Halt
Later from TrivarX
- September 2025 Quarterly Activities Report and Appendix 4C
- TRI Exercises Option to Advance Acquisition of Stabl-Im
- Positive results from US-veteran mental health trial
- December 2025 Quarterly Activities Report and Appendix 4C
- Appendix 4D & Half-Year Financial Report to 31 December 2025
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX